Experimental vaccine protects monkeys from Ebola virus
Washington: An experimental vaccine protects monkeys from not only the two of the deadliest Ebola virus species, but also against a newer Ebola variant BEBOV, identified in 2007.
Ebola symptoms are headaches, fevers, chills, muscle aches and loss of appetite. Later, the patients experience diarrhoea, rash, sore throat, vomiting, abdominal pain and chest pain.
They have limited kidney and liver functions, besides internal and external bleeding. Patients die of shock, which is eight to 17 days after infection. The Ebola virus also suppresses the immune system.
Nancy J Sullivan of the Vaccine Research Centre at the National Institute of Allergy and Infectious Diseases (NIAID) led the study team, including those from the US Army Medical Research Institute of Infectious Diseases and Centres for Disease Control.
Currently, there are no specific treatments or vaccines available to control Ebola outbreaks.
"The important work by Dr Sullivan and her colleagues shows that it is possible to generate immunity to newly identified species of Ebola virus with a vaccine originally designed to protect against a different species," said NIAID director Anthony S Fauci.
"This finding will guide future vaccine design and may open an avenue for developing a single vaccine that works against both known and emerging Ebola virus species."
More importantly, the experimental vaccine induces a robust reaction by the cellular arm of the immune system. The cellular arm includes T-cells, which help orchestrate the overall immune response.
"An ideal Ebola vaccine would stimulate broad immunity so that we wouldn`t have to scramble to create entirely new vaccines whenever new virus species are identified," notes Sullivan, according to a NIAID release.
Now the research team is evaluating what parts of the T-cell response were critical to the vaccine`s success against BEBOV.
"Once we identify those critical aspects, we can design future vaccines to better elicit that desired immune cell-based activity and perhaps make a single vaccine that protects against all Ebola virus species," says Sullivan.
Their findings appeared on May 20 in the open-access PLoS Pathogens.
More from India
More from World
More from Sports
More from Entertaiment
- Watch - IIT-Kharagpur develops superpower drone 'BHIM' that could aid soldiers in war zones
- Anti-Romeo squad launched: Has moral policing started in UP?
- Jharkhand: Congress leader, 3 others killed in shootout in Dhanbad
- CM Yogi’s cleanliness drive: UP cops clean up police stations
- Do not put unnecessary pressure on police: PM Modi tells UP BJP MPs
- Hukumdev Narain Yadav to be new Vice-President of India?
- 400 Trinamool Congress members including many TMC stalwarts join BJP in Tripura
- Bhagat Singh, Sukhdev, Rajguru were hanged on 23 March 1931 – This is how PM Modi paid tribute today
- Kapil Sharma fight on flight row: Did Sunil Grover, Ali Asgar and Chandan Prabhakar skip shoot?
- Mohammad Kaif welcomes Yogi Adityanath's appointment as new Uttar Pradesh chief minister